|
|||||
|
|
Risk of acute myocardial infarction,stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers — a cohort study using the Clinical Practice Research Datalink |
|
| Authors: | Mark S Levenson Martin Rose Ya‐Hui Hsueh David J Graham |
| Institution: | 1. Office of Biostatistics, U.S. Food and Drug Administration, MD, USA;2. Office of New Drugs, U.S. Food and Drug Administration, MD, USA;3. Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, MD, USA |
| Abstract: | |
| Keywords: | olmesartan angiotensin receptor blockers (ARBs) acute myocardial infarction (AMI) death pharmacoepidemiology |